Study type: In vivo/preclinical · Verification: Citation verified
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
Journal of immunology (Baltimore, Md. : 1950) · 1999
Study scale: Not reported in the declared source.
Bibliographic details only: Open source record
Product or molecular entity relationships
- VIP: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
No public summary
No plain-language summary is published in this record. Summary availability is separate from its verification. Consult the cited publication when a public link is available.
Limitations and uncertainty
Not reported in the declared source.
Citation verified. The PMID shown was confirmed at PubMed on 2026-08-16, and its study type matched the catalog’s source record. It is held as a citation, not evidence. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.